Regulation & law · 05/02/2016Updated: 10/17/2026 · 1 min read
DEA Proposes Scheduling of Four Synthetic Cannabinoids, Including PB-22 and AB-FUBINACA, as Schedule I Controlled Substances
Summary
The Drug Enforcement Administration has proposed placing four synthetic cannabinoids, including PB-22 and AB-FUBINACA, into Schedule I of the Controlled Substances Act, subject to formal rulemaking and a hearing. This action would impose strict regulatory controls and penalties on those who handle or manufacture these substances.